4C9-66145-21970
2 vaccinations
1 coded response
4 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 431 / OH
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-05
Dose 1 — Moderna
-
2021-03-30
Registered in v-safe
- 2021-03-30
-
2021-04-02
Dose 2 — Moderna
- 2021-04-02
-
2021-04-04
Survey response — days 1–6 daily, dose 2MedDRA: Heart rate increased, Muscle spasms, Muscle tightness, Respiratory rate increased, Uterine spasm — Feeling: Poor · Site: Pain, Redness, Swelling · Headache, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: High heart rate, high respiratory rate, lower back spasms and muscle tightness, hip tightness and stomach/uterus tightness/cramp.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-05 | Moderna | |
| 2 | 2021-04-02 | Moderna |
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): High heart rate, high respiratory rate, lower back spasms and muscle tightness, hip tightness and stomach/uterus tightness/cramp.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Heart rate increased | ✓ | ✓ | ✓ |
| SRO | Muscle spasms | ✓ | ✓ | ✓ |
| SRO | Muscle tightness | ✓ | ✓ | ✓ |
| SRO | Respiratory rate increased | ✓ | ✓ | ✓ |
| SRO | Uterine spasm | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release